Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:PODD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePODDInsulet$341.78+1.1%$311.59$225.37▼$353.50$24.06B1.36530,837 shs472,873 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePODDInsulet0.00%-1.91%+8.23%+12.20%+50.08%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePODDInsulet$341.78+1.1%$311.59$225.37▼$353.50$24.06B1.36530,837 shs472,873 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePODDInsulet0.00%-1.91%+8.23%+12.20%+50.08%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PricePODDInsulet 2.89Moderate Buy$335.12-1.95% DownsideCurrent Analyst Ratings BreakdownLatest PODD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/8/2025PODDInsuletOppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$324.00 ➝ $365.008/21/2025PODDInsuletBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetEqual Weight$266.00 ➝ $300.008/8/2025PODDInsuletCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$331.00 ➝ $353.008/8/2025PODDInsuletRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$330.00 ➝ $350.008/8/2025PODDInsuletWells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$330.00 ➝ $350.008/7/2025PODDInsuletMorgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight8/7/2025PODDInsuletJefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy7/8/2025PODDInsuletCitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy6/16/2025PODDInsuletTruist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$365.00(Data available from 9/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookPODDInsulet$2.36B10.20$4.49 per share76.17$17.27 per share19.79Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DatePODDInsulet$418.30M$3.29103.8868.772.8110.01%23.78%9.30%11/6/2025 (Estimated)Latest PODD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025PODDInsulet$0.92$1.17+$0.25$0.32$612.31 million$649.10 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthPODDInsuletN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioPODDInsulet0.642.261.81Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipPODDInsuletN/AInsider OwnershipCompanyInsider OwnershipPODDInsulet0.39%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionablePODDInsulet3,90070.39 million70.12 millionOptionablePODD HeadlinesRecent News About These CompaniesAcadian Asset Management LLC Grows Stock Holdings in Insulet Corporation $PODD1 hour ago | marketbeat.comUBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Sells 910,050 Shares of Insulet Corporation $PODD1 hour ago | marketbeat.com1,487 Shares in Insulet Corporation $PODD Acquired by United Services Automobile Association1 hour ago | marketbeat.comInsulet Corporation $PODD Shares Acquired by Goldman Sachs Group Inc.2 hours ago | marketbeat.comVident Advisory LLC Purchases Shares of 822 Insulet Corporation $PODDSeptember 13 at 3:13 AM | marketbeat.comInsulet eyes Middle East expansion as McEvoy talks future plansSeptember 12 at 1:29 PM | drugdeliverybusiness.comD3 Reasons Investors Love Insulet (PODD)September 12 at 1:29 PM | msn.comWhy Insulet (PODD) is a Top Growth Stock for the Long-TermSeptember 12 at 10:45 AM | zacks.comInsulet (NASDAQ:PODD) Stock Price Down 5% on Insider SellingSeptember 12 at 10:44 AM | marketbeat.comInsulet Corporation $PODD Shares Acquired by Geneos Wealth Management Inc.September 12 at 9:16 AM | marketbeat.comQ2 Earnings Outperformers: ResMed (NYSE:RMD) And The Rest Of The Patient Monitoring StocksSeptember 12 at 8:28 AM | msn.comFred Alger Management LLC Sells 6,153 Shares of Insulet Corporation $PODDSeptember 12 at 5:19 AM | marketbeat.comAlliancebernstein L.P. Raises Stock Position in Insulet Corporation $PODDSeptember 12 at 3:54 AM | marketbeat.comInsulet (NASDAQ:PODD) Shares Down 5% After Insider SellingSeptember 12 at 2:23 AM | americanbankingnews.comInsider Selling: Insulet (NASDAQ:PODD) SVP Sells 687 Shares of StockSeptember 11 at 5:43 PM | marketbeat.comInsulet (NASDAQ:PODD) SVP Sells $278,001.57 in StockSeptember 11 at 5:43 PM | marketbeat.com1,226 Shares in Insulet Corporation $PODD Purchased by MBB Public Markets I LLCSeptember 11 at 5:45 AM | marketbeat.comMeiji Yasuda Asset Management Co Ltd. Trims Stock Holdings in Insulet Corporation $PODDSeptember 11 at 5:28 AM | marketbeat.comInsider Decision: Prem Singh Offloads $238K Worth Of Insulet StockSeptember 11 at 2:03 AM | benzinga.comInsulet (NASDAQ:PODD) Sets New 52-Week High on Analyst UpgradeSeptember 10, 2025 | marketbeat.comInsulet (NASDAQ:PODD) Now Covered by OppenheimerSeptember 10, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePODD Company DescriptionsInsulet NASDAQ:PODD$341.78 +3.84 (+1.14%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$341.82 +0.05 (+0.01%) As of 09/12/2025 06:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 09/08 - 09/12 Meta's $600B U.S. Investment: Bearish or Bullish for Shares? Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio Tesla's U.S. Market Is At An 8-Year Low... How Bad Could It Get? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
